Real-world efficacy of dupilumab re-administration after discontinuation in patients with atopic dermatitis

被引：0
|
作者：
Matsutani, Masako [1 ]
Imai, Yasutomo [1 ]
Miyamoto, Shoko [1 ]
Inoue, Yukako [1 ]
Natsuaki, Masaru [1 ]
Kanazawa, Nobuo [1 ]
机构：
[1] Hyogo Med Univ, Dept Dermatol, Nishinomiya, Japan
来源：
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY | 2024年 / 7卷
基金：
日本学术振兴会;
关键词：
dupilumab; atopic dermatitis; eczema; skin rash; biologic-free remission;
D O I：
10.3389/jcia.2024.12480
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Use of Dupilumab for Adult-Onset Atopic Dermatitis: A Real-World Retrospective Study
    Sood, Siddhartha
    Georgakopoulos, Jorge R.
    Maliyar, Khalad
    Sachdeva, Muskaan
    Mufti, Asfandyar
    Yeung, Jensen
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024, 28 (01) : 96 - 97
  • [32] Real-World Experience of Long-Term Dupilumab Treatment for Atopic Dermatitis in Korea
    Lee, Dong Hun
    Ko, Hyun Chang
    Na, Chan Ho
    Roh, Joo Young
    Park, Kui Young
    Park, Young Lip
    Park, Young Min
    Park, Chang Ook
    Park, Chun Wook
    Bae, Youin
    Seo, Young-Joon
    Son, Sang Wook
    Ahn, Jiyoung
    Jung, Hye Jung
    Yang, Jun-Mo
    Won, Chong Hyun
    Yoo, Kwang Ho
    Lew, Bark Lynn
    Lee, Sang Eun
    Lee, Sung Yul
    Lee, Seung-Chul
    Lee, Yang Won
    Lee, Ji Hyun
    Jang, Yong Hyun
    Jeon, Jiehyun
    Han, Tae-Young
    Cho, Sang Hyun
    [J]. ANNALS OF DERMATOLOGY, 2022, 34 (02) : 157 - 160
  • [33] Real-world efficacy and safety of dupilumab in Chinese patients with atopic dermatitis: a single-centre, prospective, open-label study
    Gu, C.
    Wu, Y.
    Luo, Y.
    Wang, S.
    Yin, H.
    Gao, Y.
    Wang, C.
    Yao, X.
    Li, W.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (07) : 1064 - 1073
  • [34] Safety and efficacy of discontinuation and re-administration of infliximab after long term continuous therapy in patients with ankylosing spondylitis
    Baraliakos, X.
    Listing, J.
    Brandt, J.
    Sieper, J.
    Braun, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A44 - A44
  • [35] Real-world efficacy and safety of dupilumab for atopic dermatitis in a Hispanic population: A single-center retrospective cohort study
    Santiago-Vazquez, Marely
    Pelet, Natalia
    Cuesta, Jose M.
    Michelen, Eduardo
    Ramos, Alvaro J.
    Martin, Rafael F.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB199 - AB199
  • [36] Efficacy of Dupilumab in Children 6 Months to 11 Years Old With Atopic Dermatitis: A Retrospective Real-World Study in China
    Yang, Nali
    Ye, Yahui
    Shao, Junyi
    Wu, Hanwen
    Xu, Qiuyang
    Zhu, Jilin
    Liu, Jingjing
    Li, Zhiming
    [J]. DERMATITIS, 2024, 35 : S39 - S46
  • [37] Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab
    Miyamoto, Shoko
    Imai, Yasutomo
    Natsuaki, Masaru
    Yamanishi, Kiyofumi
    Kanazawa, Nobuo
    [J]. ACTA DERMATO-VENEREOLOGICA, 2022, 102
  • [38] Real-world effectiveness and safety of dupilumab in patients with moderate and severe atopic dermatitis: 2-year experience
    Fujiwara, Chisako
    Uchiyama, Akihiko
    Inoue, Yuta
    Ishikawa, Mai
    Motegi, Sei-ichiro
    [J]. JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2023, 6 (03) : 88 - 93
  • [39] Baseline characteristics of the first real-world atopic dermatitis patients on Dupilumab in Germany - interim analysis of the PROLEAD study
    Riebel, S.
    Augustin, M.
    Bley, O.
    Schmitt, J.
    Sebastian, M.
    Zaun, S.
    Thaci, D.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 190 - 190
  • [40] Comprehensive real-world comparisons between baricitinib and dupilumab treatments for moderate severe atopic dermatitis
    Cho, Yung-Tsu
    Lee, Meng-Sui
    Chang, Wen -Yu
    Lu, Yea-Ting
    Chu, Chia -Yu
    Chan, Tom C.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (07):
12345